Pharmaceutical And OLED Production At The Merck KGaA Laboratory

A laboratory technician collects a sample of Concor blood pressure tablets during the film-coating process in the laboratories at the Merck KGaA headquarters in Darmstadt, Germany, on Wednesday, June 25, 2014. Merck, the maker of the Erbitux cancer drug, forecast a "moderate increase" in sales and profit in 2014 because of the acquisition of AZ Electronic Materials SA, a chemicals supplier to the electronics industry. Photographer: Krisztian Bocsi/Bloomberg via Getty Images
A laboratory technician collects a sample of Concor blood pressure tablets during the film-coating process in the laboratories at the Merck KGaA headquarters in Darmstadt, Germany, on Wednesday, June 25, 2014. Merck, the maker of the Erbitux cancer drug, forecast a "moderate increase" in sales and profit in 2014 because of the acquisition of AZ Electronic Materials SA, a chemicals supplier to the electronics industry. Photographer: Krisztian Bocsi/Bloomberg via Getty Images
Pharmaceutical And OLED Production At The Merck KGaA Laboratory
ACQUISTA UNA LICENZA
Come posso utilizzare questa immagine?
475,00 €
EUR

DETTAGLI

Restrizioni:
Contatta l'ufficio locale per informazioni su qualsiasi tipo di uso commerciale o promozionale.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Attestazione:
Bloomberg / Collaboratore
N. Editorial:
452647824
Collezione:
Bloomberg
Data di creazione:
25 giugno 2014
Data di upload:
Tipo di licenza:
Rights-managed
Info sulla liberatoria:
Senza liberatoria. Ulteriori informazioni
Fonte:
Bloomberg
Nome oggetto:
GERMANY MERCK